X.-C. Qiao et al. / Tetrahedron: Asymmetry 21 (2010) 1216–1220
1219
7.36 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 8.0 Hz,
2H), 5.56–5.47 (m, 2H), 5.07–5.03 (m, 2H), 4.44 (dd, J = 6.8 and
13.6 Hz, 1H), 2.49–2.39 (m, 2H), 2.34 (s, 3H). 13C NMR (100 MHz,
CDCl3) d 144.3, 143.4, 137.1, 132.4, 129.3, 127.1, 125.1, 119.7,
56.9, 41.5, 21.3. ESI-HRMS Calcd for [C18H18F3NO2SNa, M+Na]+:
392.0903. Found: 392.0898. HPLC conditions: Chiralcel OD-H col-
umn, n-hexane/2-propanol = 90:10, flow rate = 1.0 mL/min, wave-
length = 210 nm, tR = 9.6 min (minor), and tR = 11.8 min (major).
ane/2-propanol = 90:10, flow rate = 1.0 mL/min, wavelength =
210 nm, tR = 10.3 min (minor), and tR = 12.9 min (major).
4.2.10. N-(1-(2-Methoxyphenyl)but-3-enyl)-4-methylbenzene-
sulfonamide 3ja
Viscous oil, 86% yield, 64% ee. ½a D18
ꢁ
¼ ꢀ26:0 (c 1.6, CH2Cl2). 1H
NMR (400 MHz, CDCl3)
d 7.47 (d, J = 8.0 Hz, 2H), 7.07 (t,
J = 7.2 Hz, 1H), 7.01 (d, J = 8.0 Hz, 2H), 6.86 (d, J = 7.2 Hz, 1H),
6.70 (t, J = 7.2 Hz, 1H), 6.60 (d, J = 8.0 Hz, 1H), 5.60–5.54 (m, 2H),
5.00–4.96 (m, 2H), 4.45 (dd, J = 7.2 and 16.4 Hz, 1H), 3.71 (s, 3H),
2.60–2.43 (m, 2H), 2.29 (s, 3H). 13C NMR (100 MHz, CDCl3) d
156.1, 142.6, 137.5, 134.2, 128.9, 128.8, 128.3, 127.4, 126.8,
120.3, 117.8, 110.4, 56.3, 55.0, 40.0, 21.3. ESI-HRMS Calcd for
[C18H21NO3SNa, M+Na]+: 354.1134. Found: 354.1127. HPLC condi-
tions: Chiralcel OD-H column, n-hexane/2-propanol = 90:10, flow
rate = 1.0 mL/min, wavelength = 210 nm, tR = 10.1 min (minor),
and tR = 12.7 min (major).
4.2.5. N-(1-(4-Methylphenyl)but-3-enyl)-4-methylbenzenesulf-
onamide 3ea13
White solid, 89% yield, 69% ee. Mp: 120–121 °C. ½a D19
¼ þ66:4 (c
ꢁ
0.5, CH2Cl2). 1H NMR (400 MHz, CDCl3) d 7.56 (d, J = 8.0 Hz, 2H),
7.14 (d, J = 8.0 Hz, 2H), 6.97 (dd, J = 8.0 and 12.8 Hz, 4H), 5.55–
5.45 (m, 1H), 5.06–5.02 (m, 2H), 4.96–4.92 (m, 1H), 4.31 (q,
J = 6.8 Hz, 1H), 2.50–2.40 (m, 2H), 2.37 (s, 3H), 2.27 (s, 3H). HPLC
conditions: Chiralcel OD-H column, n-hexane/2-propanol = 95:5,
flow rate = 1.0 mL/min, wavelength = 210 nm, tR = 14.1 min (ma-
jor), and tR = 18.2 min (minor).
4.2.11. N-(1-(Furan-2-yl)but-3-enyl)-4-methylbenzenesulfon-
amide 3ka16
4.2.6. N-(1-(4-Methoxyphenyl)but-3-enyl)-4-methylbenzene-
White solid, 71% yield, 75% ee. Mp: 63–65 °C. ½a D18
ꢁ
¼ ꢀ44:2 (c
¼ ꢀ74:8 (c
sulfonamide 3fa15
0.5, CH2Cl2) and ½a D15
ꢁ
¼ ꢀ43:6 (c 0.5, CHCl3) [lit.16
½ ꢁ
a 2D3
White solid, 94% yield, 74% ee. Mp: 88–90 °C. ½a D18
ꢁ
¼ ꢀ69:6 (c
0.78, CHCl3) for (S)-enantiomer]. 1H NMR (400 MHz, CDCl3) d
7.62 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 8.0 Hz, 2H), 7.12 (s, 1H), 6.09
(s, 1H), 5.94 (d, J = 2.8 Hz, 1H), 5.59–5.48 (m, 1H), 5.40 (d,
J = 8.4 Hz, 1H), 5.03–4.90 (m, 2H), 4.70 (dd, J = 6.8 and 14.8 Hz,
1H), 2.57–2.42 (m, 2H), 2.36 (s, 3H). HPLC conditions: Chiralcel
OD-H column, n-hexane/2-propanol = 90:10, flow rate = 1.0 mL/
min, wavelength = 225 nm, tR = 8.6 min for (R)-enantiomer, and
tR = 10.3 min for (S)-enantiomer.
0.5, CH2Cl2). 1H NMR (400 MHz, CDCl3) d 7.54 (d, J = 8.0 Hz, 2H),
7.15 (d, J = 7.6 Hz, 2H), 6.98 (d, J = 8.4 Hz, 2H), 6.69 (d, J = 8.8 Hz,
2H), 5.55–5.43 (m, 1H), 5.08–5.00 (m, 2H), 4.87 (d, J = 6.0 Hz,
1H), 4.30 (dd, J = 6.4 and 13.2 Hz, 1H), 3.75 (s, 3H), 2.46–2.34 (m,
5H). HPLC conditions: Chiralcel OD-H column, n-hexane/2-propa-
nol = 90:10, flow rate = 1.0 mL/min, wavelength = 225 nm, tR =
14.2 min (minor), and tR = 16.0 min (major).
4.2.7. N-(1-(3-Chlorophenyl)but-3-enyl)-4-methylbenzenesulf-
4.2.12. (E)-N-(1-Phenylhexa-1,5-diene-3-yl)-4-methylbenzene-
onamide 3ga
sulfonamide 3la13
Viscous oil, 88% yield, 58% ee. ½a D18
ꢁ
¼ ꢀ45:4 (c 1.8, CH2Cl2). 1H
Viscous oil, 60% yield, 76% ee. ½a D18
ꢁ
¼ ꢀ91:2 (c 1.2, CH2Cl2). 1H
NMR (400 MHz, CDCl3) d 7.54 (d, J = 8.0 Hz, 2H), 7.14–7.09 (m,
4H), 7.01–6.94 (m, 2H), 5.55–5.44 (m, 1H), 5.41 (d, J = 6.8 Hz, 1H),
5.07–5.03 (m, 2H), 4.34 (dd, J = 6.8 and 13.6 Hz, 1H), 2.46–2.38
(m, 2H), 2.36 (s, 3H). 13C NMR (100 MHz, CDCl3) d 143.3, 142.3,
137.1, 134.1, 132.6, 129.6, 129.3, 127.3, 127.0, 126.8, 124.8, 119.5,
56.7, 41.6, 21.4. ESI-HRMS Calcd for [C17H18ClNO2SNa, M+Na]+:
358.0639. Found: 358.0645. HPLC conditions: Chiralcel OD-H col-
umn, n-hexane/2-propanol = 90:10, flow rate = 1.0 mL/min, wave-
length = 210 nm, tR = 9.2 min (minor), and tR = 12.7 min (major).
NMR (400 MHz, CDCl3) d 7.76 (d, J = 8.0 Hz, 2H), 7.26–7.10 (m,
7H), 6.26 (d, J = 16.0 Hz, 1H), 5.80 (q, J = 7.6 Hz, 1H), 5.71–5.60
(m, 1H), 5.26 (d, J = 7.6 Hz, 1H), 5.13–5.00 (m, 2H), 4.06–3.97 (m,
1H), 2.38–2.23 (m, 5H). HPLC conditions: Chiralcel OD-H column,
n-hexane/2-propanol = 95:5, flow rate = 1.0 mL/min, wavelength =
210 nm, tR = 23.6 min (major), and tR = 26.9 min (minor).
4.2.13. N-(1-Cyclohexylbut-3-enyl)-4-methylbenzenesulfon-
amide 3ma
White solid, 75% yield, 77% ee. Mp = 89–90 °C. ½a D19
¼ þ8:8 (c
ꢁ
4.2.8. N-(1-(3-Methylphenyl)but-3-enyl)-4-methylbenzenesulf-
0.5, CH2Cl2). 1H NMR (400 MHz, CDCl3) d 7.68 (d, J = 8.0 Hz, 2H),
7.21 (d, J = 8.0 Hz, 2H), 5.46–5.35 (m, 1H), 4.88–4.81 (m, 2H),
4.66 (d, J = 8.8 Hz, 1H), 3.06–2.99 (m, 1H), 2.35 (s, 3H), 1.99 (t,
J = 6.4 Hz, 2H), 1.63–1.48 (m, 5H), 1.33–1.26 (m, 1H), 1.10–0.77
(m, 5H). 13C NMR (100 MHz, CDCl3) d 142.1, 137.4, 132.7, 128.5,
126.1, 117.3, 57.1, 39.7, 34.9, 28.1, 27.4, 25.3, 25.1, 20.5. ESI-HRMS
Calcd for [C17H25NO2SNa, M+Na]+: 330.1498. Found: 330.1500.
HPLC conditions: Chiralcel OD-H column, n-hexane/2-propa-
nol = 98:2, flow rate = 1.0 mL/min, wavelength = 210 nm, tR =
17.0 min (minor), and tR = 20.0 min (major).
onamide 3ha
Viscous oil, 88% yield, 46% ee. ½a D18
ꢁ
¼ ꢀ36:5 (c 1.75, CH2Cl2). 1H
NMR (400 MHz, CDCl3) d 7.54 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 8.0 Hz,
2H), 7.06 (t, J = 7.6 Hz, 1H), 6.94 (d, J = 7.6 Hz, 1H), 6.88 (d,
J = 7.6 Hz, 1H), 6.78 (s, 1H), 5.58–5.47 (m, 1H), 5.21 (br, 1H),
5.07–5.02 (m, 2H), 4.33 (dd, J = 6.8 and 13.6 Hz, 1H), 2.50–2.40
(m, 2H), 2.36 (s, 3H), 2.18 (s, 3H). 13C NMR (100 MHz, CDCl3) d
142.9, 140.1, 137.8, 137.5, 133.2, 129.1, 128.2, 128.0, 127.2,
127.1, 123.6, 119.0, 57.2, 41.8, 21.4, 21.2. ESI-HRMS Calcd for
[C18H21NO2SNa, M+Na]+: 338.1185. Found: 338.1191. HPLC condi-
tions: Chiralcel OD-H column, n-hexane/2-propanol = 90:10, flow
rate = 1.0 mL/min, wavelength = 210 nm, tR = 8.3 min (minor), and
tR = 10.6 min (major).
4.2.14. N-(1-Phenylbut-3-enyl)-4-trifluoromethylbenzenesulf-
onamide 3na
White solid, 62% yield, 60% ee. Mp: 82–84 °C. ½a D15
¼ þ24:6 (c
ꢁ
0.98, CH2Cl2). 1H NMR (400 MHz, CDCl3) d 7.69 (d, J = 8.4 Hz, 2H),
7.51 (d, J = 8.0 Hz, 2H), 7.14–7.07 (m, 3H), 6.99–6.97 (m, 2H),
5.63–5.53 (m, 1H), 5.41 (d, J = 6.8 Hz, 1H), 5.11–5.07 (m, 2H),
4.46 (dd, J = 6.8 and 13.6 Hz, 1H), 2.48 (t, J = 7.2 Hz, 2H). 13C NMR
(100 MHz, CDCl3) d 144.0, 139.4, 133.9 (q), 132.8, 128.4, 127.6,
127.5, 126.6, 125.6 (q), 119.4, 57.6, 41.8. ESI-HRMS Calcd for
[C17H16F3NO2SNa, M+Na]+: 378.0746. Found: 378.0750. HPLC con-
ditions: Chiralcel OD-H column, n-hexane/2-propanol = 90:10,
4.2.9. N-(1-(2-Chlorophenyl)but-3-enyl)-4-methylbenzenesulf-
onamide 3ia15
White solid, 93% yield, 65% ee. Mp: 98–100 °C. ½a D18
¼ ꢀ44:2 (c
ꢁ
0.5, CH2Cl2). 1H NMR (400 MHz, CDCl3) d 7.60 (d, J = 8.0 Hz, 2H),
7.21–7.05 (m, 6H), 5.54–5.43 (m, 1H), 5.36–5.30 (m, 1H), 5.07–
5.01 (m, 2H), 4.80 (dd, J = 7.2 and 13.2 Hz, 1H), 2.50–2.37 (m,
2H), 2.35 (s, 3H). HPLC conditions: Chiralcel OD-H column, n-hex-